Platelet aggregometric study on whole blood of patients with ischaemic heart disease

Kathmandu University Medical Journal

Volumn 3 no. 1, Issue 9, 2005, Pages 11-16

  Lakhey, M ^a,d   Agarwal, A ^b   Badhe, B ^c  

^a Department of Pathology   (Nepal)

^b B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^c JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d KATHMANDU MEDICAL COLLEGE   (Nepal)

Author keywords

Chrono log aggrometer; Ischaemic heart disease; Platelet aggregation; Platelet function

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; THROMBOCYTE AGGREGATION;

ADULT; AGED; ASPIRIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES;

EID: 39049176952     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. th edition W.B. Saunders: 517-582.
2. Ross R, Glomset JA: The pathogenesis of atherosclerosis, N Eng J Med, 314:488-500; 1986.
3. Haft JI: Role of blood platelets in coronary artery disease. Am J Cardiol 43:1197 0-206; 1979.
4. Mehta J, Mehta P, Hovalek C. Role of platelets and prostaglandin in coronary artery disease. AM J. Cardiol, 48:366-73, 1981.
5. Salky N, Dugdale M. Platelet abnormalities in ischaemic heart disease. Am J Cardiol, 32:612-617; 1973.
6. Steele PP, Weily HS, Davies W, Genton E: Platelet function studies in coronary artery disease. Circulation 48:1194-2000; 1973.
7. Besterman E, Myat G, Travadi. Diurnal variations of platelet stickiness compared with effects produced by adrenaline. BrMed J, 1:597; 1967.
8. O'Brien JR, Heywood JB, Heady JA. The quantitation of platelet aggregation induced by four compounds. Thrombosis Diath Haemorr, 16:752; 1966.
9. Zahavi J, Dreyfeuss F. An abnormal pattern of adenosine diphosphate induced platelet aggregation in acute myocardial infarction. Thromb Diath Haemorrh, 21(1): 76-88; 1969.
10. Vilen L, Johansson S, Kuthi J, Garberg S, Vedu A, Wilhelmsson C. Adenosine diphosphate induced platelet aggregation in young female survivors of acute myocardial infarction and their female controls. Acta Med Scand 217(1)-13; 1985.
11. Adlie NG, Knglough R, Hard Schwarz LJ. In vitro thrombosis and platelet aggregation in myocardial infarction .Br Med J, 1:888; 1966.
12. Hampton JR: The study of platelet behavior and its relevance to thrombosis, J Atheroscler Res, 7:729-746; 1967.
13. 2 production in-patients of IHD: relationship to coronary pathoanatomy, risk factors and clinical manifestations. AM Heart J, 101; 185-94; 1981.
14. Sorkin RP, Tikarksy JM, Huber Smith MJ, Steiger JF, McCann DS, In vivo platelet aggregation and plasma catecholamines in AMI Am Heart J, 104:1255-61; 1982.
15. Hennekens CH, Burning JE, Sandercock P: Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation, 80:749-756;1989.
16. Eldwood PC, Reynaud S, sharp DS, Beswich AD, O' Brein , JR, Yarnell JSG. Ischaemic heart disease and platelet aggregation. Circulation ,83:38-44; 1991.
17. Jick H, Miethinen Os: Regular aspirin use and MI. Br. Med J, 1;1-57;1976.
18. Born GVR. Quantitative investigation into the aggregation of blood platelet. J. Physiol Lond., 162-67;1962.
19. Willich SN, Arntz WR, Lowel M. Lewis M, Schroder R. Wake up time, thrombocyte aggregation and the risk of acute coronary heart disease; 81(Suppl) 2:9509; 1992.
20. Mackie J, Jones R, Machin SJ. Platelet impedence aggregation in whole blood and its inhibition by antiplatelet drug. J Clin Path,37:874-8.1984.